Atripla

Type: Product
Name: Atripla
First reported Apr 16 2014 - Updated Apr 16 2014 - 1 reports

HIV market growth to be impacted by patent expiries

Due to patent expirations of several key therapies, the human immunodeficiency virus (HIV) treatment market value will increase at a slow pace in the coming years, from $14.3 billion in 2012 to $16.3 billion by 2019, at a compound annual growth rate (CAGR) ... [Published Pharma Letter - Apr 16 2014]
Entities: HIV/AIDS, Tenofovir, Patent
First reported Apr 15 2014 - Updated Apr 15 2014 - 1 reports

Predicting kidney problems

American doctors have developeda risk score to predict which men living with HIV have the highest risk ofdeveloping chronic kidney disease.Without HIV treatment, people with HIV can develop kidneydisease. Some antiretroviraldrugs have also been linked ... [Published Aidsmap - Apr 15 2014]
First reported Apr 11 2014 - Updated Apr 11 2014 - 1 reports

Early ACA enrollees more likely to be sicker, suffer from chronic disease

The first people to enroll in the health insurance exchanges created under the Affordable Care Act were more likely to be sicker or suffering from a chronic disease than the average patient, according to a new study that analyzed prescription drug us ... [Published Medical Economics - Apr 11 2014]
First reported Apr 11 2014 - Updated Apr 11 2014 - 1 reports

National Sales Manager

We have an exciting opportunity for a one of two position who will lead and manage the HIV North sales team. This team is accountable for delivering half of the c.$400 million annual turnover of the UK & Ireland HIV portfolio. It is currently in the launch ... [Published PharmaDiversity - Apr 11 2014]
First reported Apr 09 2014 - Updated Apr 10 2014 - 1 reports

Sicklier patients enroll in Obamacare, study finds

Over all, early users of marketplace plans appeared to be filling prescriptions for drugs at rates similar to people with coverage through their employers. Another pharmacy-benefit manager, Prime Therapeutics, said it was seeing slightly higher rates ... [Published CNBC - Apr 09 2014]
First reported Apr 10 2014 - Updated Apr 10 2014 - 1 reports

Starting HIV Treatment Amidst Anger and Depression

Greg FreemanIt's never an easy decision when it comes to treatment. I wasn't even sure I could accept that I was HIV positive. So many aspects of my life felt -- and were -- really uncertain. It was August 2010 when I found out that I was HIV positive. ... [Published The Body - Apr 10 2014]
First reported Apr 09 2014 - Updated Apr 09 2014 - 1 reports

A frustrated letter to my trusted doctor

Dear Dr Kinyanjui,It is now 32 days since you put me on the wonder drug, Atripla.I feel that I need to give you an update on how I am fairing. I am headed to your office to drop the remaining drugs and to let you know that I am done with them.To start ... [Published Daily Nation - Apr 09 2014]
First reported Apr 09 2014 - Updated Apr 09 2014 - 1 reports

Study Looks at Earliest Health Law Enrollees

c.2014 New York Times News ServicePeople who signed up early for insurance through the new marketplaces were more likely to be prescribed drugs to treat pain, depression and HIV and were less likely to need contraceptives, according to a new study that ... [Published Columbus - Apr 09 2014]
First reported Apr 08 2014 - Updated Apr 08 2014 - 1 reports

24-Year-Old Former Porn Model Given an AIDS Diagnosis

So I'm doing my usual Facebook searching, and came across a very interesting video of a former porn model who, at 24 years old, was diagnosed with AIDS. Justin Washington, more publicly known as Snow Bunni, recorded a video for The Luckey Star Blog of ... [Published The Body - Apr 08 2014]
First reported Apr 05 2014 - Updated Apr 05 2014 - 1 reports

Antiretroviral Therapy in 2014: How Does a Doctor Choose?

While development of drugs for HIV infection has definitely slowed over the last several years, treatment options continue to expand and improve, making antiretroviral therapy (ART) easier, better tolerated, and more convenient. In this article, I'll ... [Published The Body - Apr 05 2014]
First reported Apr 02 2014 - Updated Apr 02 2014 - 1 reports

Starting Antiretrovirals Wasn't an Option

Aaron LaxtonStarting on ARVs [antiretrovirals] wasn't an option. From all the research I had done, I knew that the quicker that I started medications, the better chance I would have to remain healthy. I was diagnosed on June 6, 2011, and almost a month ... [Published The Body - Apr 02 2014]
First reported Apr 01 2014 - Updated Apr 01 2014 - 1 reports

Atripla, Vivid Dreams and Getting Past the Undetectable Brick Wall

Part of the Series Other Sides of HIV : People Taking HIV Meds Share Stories About Side EffectsMikeAfter being told I was HIV positive, for me it was a no-brainer. I started medications right away; when I say right away, it was more like three months, ... [Published The Body - Apr 01 2014]

Quotes

...what kind of health care challenges do they have," said Karen M Ignagni, president of America's Health Insurance Plans, which represents insurers. "Pharmacy claims are often an indicator for medical claims, and it's often the case that they provide a real insight into overall trends."
"This is a snapshot of the population early on," said Julie Huppert, Express Scripts' vice president of health care reform. "The hope is the young and healthy come into the system in the later weeks of the enrollment period."
..."The side effects are a bitch!" he says jokingly but serious at the same time. "I felt as though I had the pneumonia all over again. I was weak and couldn't walk, was like the flu x10." He also experienced a lot of the other common symptoms of Atripla such as the dizziness and his vivid dreams...
"We have to think about the cognitive domain -- the triple D's: dementia, depression, and poor disposition or mood, and how that affects physical frailty and a compromised immune system" he said

More Content

All (44) | News (40) | Reports (0) | Blogs (4) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Stock Update: Gilead Sciences Inc (NASDAQ:GILD)... [Published Jutia Group - Apr 17 2014]
If This Biotech Drops Much Further I'm Going to... [Published Motley Fool Discussion Boards - Apr 17 2014]
HIV market growth to be impacted by patent expi... [Published Pharma Letter - Apr 16 2014]
Predicting kidney problems [Published Aidsmap - Apr 15 2014]
Company Update (NASDAQ:GILD): Texas Medicaid ho... [Published Jutia Group - Apr 11 2014]
Study: Obamacare enrollees older, sicker and mo... [Published U-T San Diego - Apr 11 2014]
National Sales Manager [Published PharmaDiversity - Apr 11 2014]
Early ACA enrollees more likely to be sicker, s... [Published Medical Economics - Apr 11 2014]
Five Star Stock Watch: Gilead Sciences [Published Benzinga.com - Apr 10 2014]
Starting HIV Treatment Amidst Anger and Depression [Published The Body - Apr 10 2014]
A frustrated letter to my trusted doctor [Published Daily Nation - Apr 09 2014]
Sicklier patients enroll in Obamacare, study finds [Published CNBC - Apr 09 2014]
Early Drug Claims Suggest Exchange Plan Enrolle... [Published Kaiser Health News - Apr 09 2014]
Study Looks at Earliest Health Law Enrollees [Published Columbus - Apr 09 2014]
24-Year-Old Former Porn Model Given an AIDS Dia... [Published The Body - Apr 08 2014]
Antiretroviral Therapy in 2014: How Does a Doct... [Published The Body - Apr 05 2014]
CROI 2014: Researchers Discuss HIV, Aging, and ... [Published HIV and Hepatitis.com - Apr 04 2014]
Starting Antiretrovirals Wasn't an Option [Published The Body - Apr 02 2014]
Gilead/J&J NDA Could Mean Another Fixed-Dose Re... [Published Health News Daily - Apr 02 2014]
Gilead Sciences: Strong Long-Term Growth At A B... [Published Seeking Alpha - Apr 01 2014]
Atripla, Vivid Dreams and Getting Past the Unde... [Published The Body - Apr 01 2014]
Risk score can help predict which people living... [Published Aidsmap - Mar 31 2014]
Starting HIV Treatment and Corporate Greed: An ... [Published The Body - Mar 29 2014]
Company Update: Gilead Sciences Inc (NASDAQ:GIL... [Published Jutia Group - Mar 28 2014]
Tobira Therapeutics Appoints Chairman Laurent F... [Published Yahoo! Finance - Mar 26 2014]
Sovaldi's Patent War [Published Seeking Alpha - Mar 24 2014]
In Battle of First-Line HIV Drugs, Raltegravir ... [Published The Body - Mar 21 2014]
Gilead Sciences Inc (NASDAQ:GILD) | U.S. lawmak... [Published Jutia Group - Mar 21 2014]
Biotech Stock Mailbag: Amarin, Cytrx, Sangamo a... [Published The Street Latest - Mar 21 2014]
CROI 2014: Heart Attack Link to Abacavir Persis... [Published HIV and Hepatitis.com - Mar 21 2014]
1 2
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Gilead Sciences: What Happened Today? [Published BARRONS.com Stocks To Watch Today - Mar 07 2014]
Shares of Gilead Sciences (GILD) fell 3.6% today, and the experts I spoke with said that they didn’t see a catalyst for the drop, one that dragged the entire biotech sector down with it. Now there are two possibilities. StreetInsider.com and the Fly On ...
Anyone Could Spare Me On Atripla? [Published HealthBoards - Feb 03 2014]
Hi, I was wondering if anyone could spare maybe 2 or 3 Atripla tablets? (I live in Baton Rouge). I requested a Refill from my pharmacy and was told that they were unable to refill my prescription because it's showing that I am no longer covered. I filled ...
Drug Patent Expirations for November 21 2013 [Published Biotech Blog - Nov 22 2013]
Copyright © thinkBiotech If your reader cannot render the information below, go tohttp://www.DrugPatentWatch.com/innovation to see the latest expirationsbody { font-family:Calibri, tahoma, arial,sans-serif;}table { font-size:12px; font-family:Calibri, ...
Drug Patent Expirations in November 2013 [Published Biotech Blog - Nov 11 2013]
Copyright © thinkBiotech Drug Patent Expirations for November 2013TradenameApplicantGeneric NamePatent NumberPatent Expiration SAMSCA Otsuka America Pharm tolvaptan 5,258,510 Nov 2, 2013 PROPECIA Merck finasteride 5,571,817 Nov 5, 2013 ACIPHEX ...
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.